Vivos therapeutics schedules release of first quarter 2023 financial results and conference call

Littleton, colo., june 06, 2023 (globe newswire) -- vivos therapeutics, inc. (“vivos” or the “company'') (nasdaq: vvos), a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from a variety of health conditions, many of which are associated with breathing related sleep issues arising from certain dentofacial abnormalities, today announced it plans to release its first quarter 2023 financial results after market close on thursday, june 8, 2023.
VVOS Ratings Summary
VVOS Quant Ranking